Further tissue microarray analysis shows that the expression levels of OTUD3 are decreased, concomitant with reduction of PTEN abundance, in human breast cancer, hepatocellular cancer, colon cancer, and cervical cancer. This evidence concerns the gene OTUD3 and breast carcinoma.